Narrow your search

Library

KU Leuven (4)

UCLouvain (3)

EhB (1)

KBR (1)

LUCA School of Arts (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLL (1)

ULB (1)

More...

Resource type

book (3)

dissertation (3)


Language

English (4)

French (1)

German (1)


Year
From To Submit

2013 (1)

2005 (1)

2002 (1)

2001 (1)

2000 (1)

More...
Listing 1 - 6 of 6
Sort by

Book
Essais d'identification des composés responsables de la cytotoxicité d'extraits d'Hymenocardia acida Tul
Authors: --- ---
Year: 2001 Publisher: Bruxelles: UCL. Faculté de pharmacie et des sciences biomédicales,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Book
Natural products in cancer prevention and therapy
Authors: ---
ISBN: 3642345743 9783642345746 Year: 2013 Publisher: Heidelberg: Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Intra-tumoural blood vessels and hypoxia : targets for treatment and imaging to improve anti-cancer therapies : pre-clinical investigations
Authors: ---
Year: 2002 Publisher: Leuven Acco

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Clinical pharmacology of anticancer agents in relation to formulations and administration routes
Authors: ---
ISBN: 9039319391 Year: 1999 Publisher: Utrecht Universiteit Utrecht

Loading...
Export citation

Choose an application

Bookmark

Abstract


Dissertation
Motor performance of children treated for acute lymphoblastic leukemia
Author:
ISBN: 9036712629 Year: 2000 Publisher: [S.l.] [s.n.]

Camptothecins in cancer therapy
Authors: ---
ISBN: 9781588290274 1588290271 9781592598663 9786610359509 1280359501 1592598668 1627038167 Year: 2005 Publisher: Totowa, N.J. : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critically review our current understanding of camptothecins, their shortcomings, and the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers. Additional chapters describe what is known about the biochemistry, the pharmacology, and the chemistry of the camptothecins, including the mechanism of topoisomerase and how camptothecins poison this enzyme, the use of animal models in defining the anticancer potential of camptothecins, and the question of camptothecin resistance. Authoritative and up-to-date, Camptothecins in Cancer Therapy provides a comprehensive summary of camptothecin research, as well as a much-needed guide to all the latest information on their optimal therapeutic applications.

Listing 1 - 6 of 6
Sort by